Jpmorgan Chase & CO Adicet Bio, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 80,353 shares of ACET stock, worth $79,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,353
Previous 771 10321.92%
Holding current value
$79,549
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$1.07 - $1.63 $85,152 - $129,718
79,582 Added 10321.92%
80,353 $115,000
Q3 2024

Nov 08, 2024
BUY
$1.07 - $1.63 $85,152 - $129,718
79,582 Added 10321.92%
80,353 $115,000
Q2 2024

Dec 26, 2024
SELL
$1.21 - $2.4 $96,294 - $190,996
-79,582 Reduced 99.04%
771 $0
Q2 2024

Aug 12, 2024
SELL
$1.21 - $2.4 $70,751 - $140,332
-58,472 Reduced 98.7%
771 $0
Q1 2024

Dec 26, 2024
SELL
$1.76 - $3.45 $37,153 - $72,829
-21,110 Reduced 26.27%
59,243 $139,000
Q1 2024

May 10, 2024
BUY
$1.76 - $3.45 $69,366 - $135,974
39,413 Added 198.75%
59,243 $139,000
Q4 2023

Dec 26, 2024
SELL
$1.11 - $1.89 $67,180 - $114,388
-60,523 Reduced 75.32%
19,830 $37,000
Q4 2023

Feb 12, 2024
SELL
$1.11 - $1.89 $9,042 - $15,395
-8,146 Reduced 29.12%
19,830 $37,000
Q3 2023

Nov 14, 2023
BUY
$1.37 - $3.4 $2,967 - $7,364
2,166 Added 8.39%
27,976 $38,000
Q2 2023

Aug 11, 2023
BUY
$2.13 - $7.13 $5,286 - $17,696
2,482 Added 10.64%
25,810 $62,000
Q1 2023

May 18, 2023
BUY
$5.52 - $9.23 $128,240 - $214,431
23,232 Added 24200.0%
23,328 $134,000
Q1 2023

May 11, 2023
SELL
$5.52 - $9.23 $97,792 - $163,518
-17,716 Reduced 99.46%
96 $0
Q4 2022

Feb 13, 2023
SELL
$7.72 - $21.27 $4,153 - $11,443
-538 Reduced 2.93%
17,812 $159,000
Q3 2022

Nov 14, 2022
BUY
$13.43 - $18.74 $18,896 - $26,367
1,407 Added 8.3%
18,350 $261,000
Q2 2022

Aug 11, 2022
BUY
$10.26 - $20.81 $1,816 - $3,683
177 Added 1.06%
16,943 $247,000
Q1 2022

May 11, 2022
BUY
$11.53 - $19.97 $29,562 - $51,203
2,564 Added 18.05%
16,766 $335,000
Q4 2021

Feb 10, 2022
BUY
$7.37 - $17.49 $18,056 - $42,850
2,450 Added 20.85%
14,202 $247,000
Q3 2021

Nov 12, 2021
BUY
$6.29 - $9.93 $73,920 - $116,697
11,752 New
11,752 $93,000

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email